Hi J***y, I’m J***e from StrategyBrain. I came across your profile and was really impressed by your leadership in portfolio planning and business development at V***s, as well as your strong M&A and partnership experience. We’re partnering with G***m I***s to recruit a Vice President of Global Business Development,a role that will drive global BD strategy, lead M&A and licensing initiatives, and build key external collaborations. Would you be open to a brief chat to explore whether this opportunity aligns with your career goals? Best regards, J***e

Hi J***y, Great to hear you’re interested. Here’s a bit more on G***m I***s and the VP of Global Business Development role: • Company & Impact G***m I***s is a top-tier pharma/biotech with R&D, regulatory, commercial and manufacturing footprint in over 30 countries. We tackle high-impact therapies for unmet medical needs and maintain an entrepreneurial, science-driven culture. • Role & Responsibilities , Lead the design and execution of our global BD strategy, identifying and evaluating M&A, licensing and partnership opportunities to grow our portfolio (your V***s experience will be invaluable here). , Oversee cross-functional due diligence and negotiate complex deals that align with corporate goals. , Partner closely with R&D, regulatory, finance and commercial teams to integrate new assets and ensure launch readiness. , Build and maintain relationships with biotech firms, academic groups and industry consortia to source innovative assets. , Mentor and lead a team of BD managers, driving a high-performance culture. • Why This Role Is Compelling , You’ll sit at the nexus of strategy and execution, with direct input into our global roadmap and P&L. , Significant career growth: strong visibility with the executive team, and clear pathways toward C-suite. , Best-in-class resources: dedicated diligence support, experienced internal partners and a sizable BD budget. , Competitive compensation package with bonus potential and equity. Does this align with what you’re looking for? I’d be happy to dive deeper or answer any questions. If you’d like to chat, I’m available for a 20-minute call (Shanghai time) on: • Wednesday 10:00,11:30 AM CST • Thursday 2:00,4:00 PM CST Please let me know which works best, or share your preferred times. Looking forward to our conversation! Best, J***e HR Recruiter, StrategyBrain

Hi J***y, Great questions. Here’s some additional color: 1. Team size & structure - You’d lead a global BD team of 6,8 professionals: 2 regional BD managers in North America, 2 in Europe, 2 in Asia-Pacific, plus 1,2 deal analysts. - The team partners tightly with our in-house legal, finance, regulatory and R&D colleagues for end-to-end deal execution. 2. Reporting line - You’ll report directly to our Chief Strategy Officer (CSO), who sits on the Executive Leadership Team alongside the CEO and CFO. 3. Near-term priority/challenge - The biggest focus over the next 6,9 months is sourcing and closing a transformative bolt-on acquisition or licensing deal in our key therapeutic areas (oncology/immunology). In parallel, you’ll help streamline our global due-diligence processes and lead integration planning for our most recent partnership, ensuring a smooth handoff into launch readiness. Let me know if you’d like more detail or if you’d like to schedule our call to dive deeper into any of this. Best, J***e HR Recruiter, StrategyBrain

Hi J***y, Great questions. Here’s how we typically approach integration and success metrics: 1. Integration planning timeline - Kick-off: As soon as we sign the LOI, we spin up a dedicated integration PMO. - High-level blueprint (30,45 days): Define key workstreams, governance, leadership roles, and initial synergy targets. - 100-day plan (by end of diligence, ~60,75 days): Detailed playbooks for operations, R&D handoffs, regulatory filings, commercial alignment and IT integration. - Execution milestones (3,6 and 6,9 months): Track go-lives (e.g., tech transfers), first regulatory submissions, joint launch readiness activities. 2. Cross-functional involvement - R&D: Embedded from day one to assess asset risk, define technical requirements and shape the post-close roadmap. - Legal: Partners closely throughout diligence, driving contract negotiations, IP diligence and compliance checks. - Finance: Validates deal models, builds synergy cases, monitors P&L impacts and cash-flow projections. We run weekly “diligence sprints” where all functions share findings and adjust assumptions in real time. 3. Key 6,9-month BD KPIs - Pipeline health: # of qualified opportunities and total enterprise value in late-stage funnel - Conversion rate: Deals closed vs. plan (count and $ value) - Time-to-close: Average days from initial contact to signed agreement - Synergy capture: % of projected revenue/cost synergies realized in actuals - Integration milestones: % of 100-day and 6-month goals achieved on schedule - Stakeholder satisfaction: Internal net promoter scores from R&D, finance and commercial teams I’d be happy to walk you through a sample 100-day plan and scorecard. Would you be available for a 20-minute call on Wednesday at 10:30 AM CST or Thursday at 3:00 PM CST? Looking forward to digging in, J***e HR Recruiter, StrategyBrain

Hi J***y, Happy to share a high-level snapshot of how we structure our 100-day playbook and handle late-cycle risks in diligence sprints. Given your strong M&A and integration background from V***s, you’ll recognize many best practices here: 1. 100-Day Playbook Outline - Governance & PMO Launch (Days 0,15) • Establish integration steering committee (CSO, Finance, R&D leads) • Appoint dedicated PMO director (owned by VP, Global BD) - Workstream Blueprints (Days 15,45) • R&D Transfer & Asset Handoff: Detailed tech-transfer plan, lead by R&D integration manager • Regulatory & Compliance: Pre-submission checklist, owner from regulatory affairs • Commercial Alignment: Territory launch sequencing, commercial ops lead • Finance & Synergy Tracking: Revised P&L model, finance controller - Detailed Execution Plan (Days 45,75) • Milestone calendars for draft filings, pilot launches, cost-savings initiatives • Risk register with owners, mitigation actions and decision gates - Go-Live & Stabilization (Days 75,100) • First submissions or transfers complete; post-deal performance review • Transition to “run” organization; handoff dossier to functional heads 2. Escalating & Resolving Late-Cycle R&D/Finance Risks - Weekly Sprint Format: Each function presents updates against key diligence themes - Risk Triage: Any “red-flag” items (e.g., unexpected CMC gap or warranty exposure) are logged in a shared risk register with A/B severity ratings - Immediate Huddle: For Severity A risks, we convene a cross-functional mini-war room (R&D head, CFO delegate, legal counsel, BD lead) within 24 hours - Action & Escalation Path: • Containment Plan: Quick-win mitigation (e.g., bridge testing protocol or holdback in term sheet) • Executive Brief: If residual risk exceeds our pre-agreed threshold, the CSO and CFO step in to decide on deal contours or ask for vendor guarantees • Document & Report: Updates flow back into a live dashboard to keep the steering committee and Board briefed If you’d like to review the full deck of sample slides or walk through a real-life case, I’m happy to set up a quick call. I have availability Thursday at 3:00 PM CST,does that work for you? Best, J***e HR Recruiter, StrategyBrain

Hi J***y, Great questions,here’s a quick snapshot before our Thursday 3:00 PM CST chat: 1. Synergy quantification & tracking (Days 15,45) • We build a detailed “revised P&L” template with line items for revenue synergies (e.g., cross-sell uplift, pricing harmonization) and cost synergies (e.g., supply-chain savings, SG&A optimization). • Each synergy is tied to a specific initiative, owner, and timeframe (e.g., $X MM cost reduction by Q4). • We update the P&L weekly, comparing actuals to forecast and flagging variances in our diligence sprints and PMO dashboard. 2. PMO Director role & interface • Typically, we appoint a seasoned integration lead from G***m’s M&A/Corporate Finance team (5,8 years of deal execution experience). • The PMO Director reports to the VP of Global BD, chairs the integration steering committee, and runs day-to-day coordination,scheduling cross-functional workshops, driving milestone tracking, and surfacing risks directly to BD. I’ve just shared two slides via email: one illustrates our synergy-tracking model in the revised P&L, the other profiles the PMO Director and their day-to-day interface with BD. Looking forward to walking through these on Thursday at 3:00 PM CST. Let me know if you need anything else before then. Best, J***e